Ataxic features in Corticobasal Syndrome (CBS) represent an important but often underrecognized component of the clinical phenotype. While CBS is classically characterized by asymmetric cortical signs (apraxia, cortical sensory loss, alien limb) and extrapyramidal features (rigidity, dystonia, bradykinesia), cerebellar involvement can occur in a significant subset of patients, particularly in those with certain pathological subtypes or disease variants. The presence of ataxic features has diagnostic implications, as it may suggest alternative pathologies or influence the differential diagnosis between CBS and other atypical parkinsonian syndromes.
This page provides a comprehensive review of ataxic features in CBS, including their prevalence, pathophysiology, clinical manifestations, neuroimaging findings, and management strategies.
Prevalence and Clinical Significance
Frequency of Ataxia in CBS
Cerebellar ataxia occurs in approximately 15-30% of CBS patients, though estimates vary across studies due to differences in diagnostic criteria and patient populations[@cbs2025][@pspcbs2024]. The wide range reflects:
Pathological heterogeneity: Different underlying pathologies show varying degrees of cerebellar involvement
Disease stage: Ataxic features may emerge or worsen as the disease progresses
Assessment methodology: Subtle ataxia may be missed without specialized examination
CBS subtype: Certain clinical variants show higher rates of ataxia
Clinical Implications
...
Ataxic Features in Corticobasal Syndrome
Overview
Ataxic features in Corticobasal Syndrome (CBS) represent an important but often underrecognized component of the clinical phenotype. While CBS is classically characterized by asymmetric cortical signs (apraxia, cortical sensory loss, alien limb) and extrapyramidal features (rigidity, dystonia, bradykinesia), cerebellar involvement can occur in a significant subset of patients, particularly in those with certain pathological subtypes or disease variants. The presence of ataxic features has diagnostic implications, as it may suggest alternative pathologies or influence the differential diagnosis between CBS and other atypical parkinsonian syndromes.
This page provides a comprehensive review of ataxic features in CBS, including their prevalence, pathophysiology, clinical manifestations, neuroimaging findings, and management strategies.
Prevalence and Clinical Significance
Frequency of Ataxia in CBS
Cerebellar ataxia occurs in approximately 15-30% of CBS patients, though estimates vary across studies due to differences in diagnostic criteria and patient populations[@cbs2025][@pspcbs2024]. The wide range reflects:
Pathological heterogeneity: Different underlying pathologies show varying degrees of cerebellar involvement
Disease stage: Ataxic features may emerge or worsen as the disease progresses
Assessment methodology: Subtle ataxia may be missed without specialized examination
CBS subtype: Certain clinical variants show higher rates of ataxia
Clinical Implications
The presence of ataxic features in CBS has several important implications:
Diagnostic value: Prominent ataxia early in the disease course may suggest alternative diagnoses such as multiple system atrophy (MSA) or spinocerebellar ataxia
Pathological correlations: Cerebellar signs often correlate with specific neuropathological findings
Disease progression: Ataxia may be associated with more rapid functional decline
Treatment planning: Presence of ataxia influences therapeutic approaches and rehabilitation strategies
Pathophysiology
Neuroanatomical Basis
The cerebellum can be affected in CBS through multiple mechanisms:
Direct Cerebellar Pathology
Purkinje cell degeneration: Loss of Purkinje cells in the cerebellar cortex is a recognized feature in some CBS cases[@cbsneuro2023]
Cerebellar nuclear involvement: Degeneration of deep cerebellar nuclei (dentate, globose, emboliform)
White matter tract damage: Disruption of cerebellar peduncles connecting the cerebellum to cortical and subcortical structures
Tau pathology: 4R tau deposition in cerebellar neurons and processes
Secondary Mechanisms
Brainstem involvement: Cerebellar ataxia can result from brainstem lesions affecting cerebellar afferents/efferents
Thalamic dysfunction: The cerebellum connects to the thalamus, which can be affected in CBS
Cortical-cerebellar disconnection: Damage to frontal-parietal regions disrupts cerebellar modulation
Drug-induced ataxia: Medications used for CBS symptoms (e.g., benzodiazepines, anticonvulsants) can cause or worsen ataxia
Neurochemical Changes
Cerebellar dysfunction in CBS involves:
GABAergic dysfunction: Reduced GABAergic transmission in cerebellar circuitry
Climbing fiber abnormalities: Disruption of olivary-climbing fiber inputs to Purkinje cells
Monoaminergic changes: Alterations in cerebellar serotonin and norepinephrine systems
Glutamatergic excitotoxicity: Potential contribution to Purkinje cell loss
Clinical Features
Gait Ataxia
Gait ataxia in CBS manifests as:
Wide-based gait: Patients adopt a broad stance for stability
Staggering and stumbling: Loss of coordinated leg movements during walking
Difficulty with tandem walking: Inability to walk heel-to-toe in a straight line
Unsteady turns: Particularly pronounced difficulty turning around
Falls: Increased fall risk due to balance impairment
Clinical pearls:
Gait ataxia in CBS is typically less severe than in classic cerebellar ataxias
May be asymmetric initially, reflecting the characteristic asymmetry of CBS
Often coexists with other motor features (rigidity, dystonia)